This is a blank check company (SPAC) incorporated in the Cayman Islands in July 2025 with no operating business. Its sole purpose is to identify a private company, merge with it, and take it public through a deSPAC transaction. The SPAC raised $168.5M in its IPO, which is held in a trust account invested in U.S. Treasury bills. The management team has 24 months from IPO closing to complete a deal; if no deal closes, the trust is liquidated and public shareholders receive $10.00 per share back. No target has been identified as of the filing date. The sponsor acquired founder shares at a nominal price representing roughly 20% of the post-IPO share count — these shares become valuable if a deal closes and expire worthless if one does not. Public shareholders can redeem their shares for their pro rata share of the trust at the time of the business combination vote. The management team is based in Dubai and claims experience across private equity, investment banking, real estate, and technology, with a focus on cross-border transactions spanning North America, the Middle East, Asia, and Europe. The team previously sponsored Iris Acquisition Corp., a $276M SPAC that completed a business combination with Liminatus Pharma. The SPAC describes itself as a generalist vehicle with a preference for small to mid-market companies with established revenues, targeting sectors including TMT, business and IT services, EdTech, logistics, FinTech, and consumer products.